{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:26:18Z","timestamp":1790108778654,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007225","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007225","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jgar.2023.02.013","type":"journal-article","created":{"date-parts":[[2023,2,26]],"date-time":"2023-02-26T15:02:18Z","timestamp":1677423738000},"page":"35-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Resistant mutations within the hepatitis B virus reverse transcriptase sequence in treatment failure patients with chronic HBV infection in Vietnam"],"prefix":"10.1016","volume":"33","author":[{"given":"Thu Kim","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duyet","family":"Van Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2023.02.013_bib0001","doi-asserted-by":"crossref","first-page":"8078","DOI":"10.1038\/s41598-019-44604-6","article-title":"Potential resistant mutations within HBV reverse transcriptase sequences in nucleos(t)ide analogues-experienced patients with hepatitis B virus infection","volume":"9","author":"Zhang","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jgar.2023.02.013_bib0002","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013","volume":"386","author":"Schweitzer","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jgar.2023.02.013_bib0003","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.4254\/wjh.v13.i9.1190","article-title":"Global prevalence of hepatitis B virus serological markers among healthcare workers: a systematic review and meta-analysis","volume":"13","author":"Mahamat","year":"2021","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jgar.2023.02.013_bib0004","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/1010539510385220","article-title":"Hepatitis B infection in Vietnam: current issues and future challenges","volume":"24","author":"Nguyen","year":"2012","journal-title":"Asia Pac J Public Health"},{"key":"10.1016\/j.jgar.2023.02.013_bib0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5501\/wjv.v11.i1.57","article-title":"Chronic hepatitis B: new potential therapeutic drugs target","volume":"11","author":"Leowattana","year":"2022","journal-title":"World J Virol"},{"key":"10.1016\/j.jgar.2023.02.013_bib0006","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jgar.2023.02.013_bib0007","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3748\/wjg.v13.i6.830","article-title":"Novel approaches towards conquering hepatitis B virus infection","volume":"13","author":"Wu","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jgar.2023.02.013_bib0008","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.antiviral.2009.12.006","article-title":"Characterization of potential antiviral resistance mutations in hepatitis B virus reverse transcriptase sequences in treatment-naive Chinese patients","volume":"85","author":"Liu","year":"2010","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jgar.2023.02.013_sbref0009","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/(SICI)1096-9071(200005)61:1<23::AID-JMV4>3.0.CO;2-X","article-title":"Properties of hepatitis B virus genome recovered from Vietnamese patients with fulminant hepatitis in comparison with those of acute hepatitis","volume":"61","author":"Yuasa","year":"2000","journal-title":"J Med Virol"},{"key":"10.1016\/j.jgar.2023.02.013_bib0010","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.1128\/JCM.42.12.5837-5841.2004","article-title":"Clinical and serological variation between patients infected with different Hepatitis B virus genotypes","volume":"42","author":"Kidd-Ljunggren","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2023.02.013_bib0011","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1128\/JCM.40.4.1207-1209.2002","article-title":"Genotypes and clinical phenotypes of hepatitis B virus in patients with chronic hepatitis B virus infection","volume":"40","author":"Kao","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2023.02.013_bib0012","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2893.2010.01301.x","article-title":"Four-year study of lamivudine and adefovir combination therapy in lamivudine-resistant hepatitis B patients: influence of hepatitis B virus genotype and resistance mutation pattern","volume":"18","author":"Inoue","year":"2011","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jgar.2023.02.013_bib0013","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1111\/j.1365-2893.2010.01360.x","article-title":"Genotypic resistance profile of hepatitis B virus (HBV) in a large cohort of nucleos(t)ide analogue-experienced Chinese patients with chronic HBV infection","volume":"18","author":"Liu","year":"2011","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jgar.2023.02.013_bib0014","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3892\/mco.2021.2275","article-title":"Entecavir resistance in a patient with treatment-naive HBV: a case report","volume":"14","author":"Marino","year":"2021","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.jgar.2023.02.013_bib0015","doi-asserted-by":"crossref","first-page":"e6712","DOI":"10.5812\/hepatmon.6712","article-title":"Drug-related mutational patterns in hepatitis B virus (HBV) reverse transcriptase proteins from Iranian treatment-naive chronic HBV patients","volume":"13","author":"Mahabadi","year":"2013","journal-title":"Hepat Mon"},{"key":"10.1016\/j.jgar.2023.02.013_bib0016","doi-asserted-by":"crossref","first-page":"334","DOI":"10.21037\/atm.2016.09.19","article-title":"Treatment for hepatitis B in patients with drug resistance","volume":"4","author":"Tacke","year":"2016","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jgar.2023.02.013_bib0017","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2893.2012.01639.x","article-title":"Hepatitis B e antigen-suppressing mutations enhance the replication efficiency of adefovir-resistant hepatitis B virus strains","volume":"20","author":"Herbers","year":"2013","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jgar.2023.02.013_bib0018","first-page":"9630","article-title":"Detection and analysis of resistance mutations of hepatitis B virus","volume":"8","author":"He","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.jgar.2023.02.013_bib0019","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S1665-2681(19)31509-1","article-title":"Evolution of hepatitis B virus during long-term therapy in patients with chronic hepatitis B","volume":"10","author":"Arrese","year":"2011","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jgar.2023.02.013_bib0020","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.clinre.2015.10.005","article-title":"Efficacy of tenofovir-based rescue therapy in patients with lamivudine-resistant hepatitis B virus: a systematic review and meta-analysis","volume":"40","author":"Wang","year":"2016","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jgar.2023.02.013_bib0021","doi-asserted-by":"crossref","first-page":"189","DOI":"10.5009\/gnl15562","article-title":"Management of antiviral resistance in chronic hepatitis B","volume":"11","author":"Lim","year":"2017","journal-title":"Gut Liver"},{"key":"10.1016\/j.jgar.2023.02.013_bib0022","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2005.06.055","article-title":"A dose-ranging study of the efficacy and tolerability of entecavir in lamivudine-refractory chronic hepatitis B patients","volume":"129","author":"Chang","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jgar.2023.02.013_bib0023","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3934\/mbe.2020032","article-title":"Compare with safety and efficacy of entecavir and adefovir dipivoxil combination therapy and tenofovir disoproxil fumarate monotherapy for chronic hepatitis B patient with adefovir-resistant","volume":"17","author":"Lai","year":"2020","journal-title":"Math Biosci Eng"},{"key":"10.1016\/j.jgar.2023.02.013_bib0024","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jhep.2010.03.020","article-title":"Lamivudine plus adefovir or entecavir for patients with chronic hepatitis B resistant to lamivudine and adefovir","volume":"53","author":"Heo","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jgar.2023.02.013_bib0025","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/gut.2010.223206","article-title":"Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B","volume":"60","author":"Patterson","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jgar.2023.02.013_bib0026","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jhep.2011.09.018","article-title":"Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort study","volume":"56","author":"Petersen","year":"2012","journal-title":"J Hepatol"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716523000309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716523000309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:01:17Z","timestamp":1761991277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716523000309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":26,"alternative-id":["S2213716523000309"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2023.02.013","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resistant mutations within the hepatitis B virus reverse transcriptase sequence in treatment failure patients with chronic HBV infection in Vietnam","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2023.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}